Psoriasis onset with tocilizumab treatment for rheumatoid arthritis

Journal of Rheumatology

Volumn 39, Issue 3, 2012, Pages 657-

  Wendling, Daniel ^a   Letho Gyselinck, Heĺeǹe ^a   Guillot, Xavier ^a   Prati, Cleḿent ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INTERLEUKIN 6 RECEPTOR; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; STAT3 PROTEIN; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; TREATMENT FAILURE; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MIDDLE AGED; PSORIASIS; SKIN; TREATMENT OUTCOME;

EID: 84857851446     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111166     Document Type: Letter

References (9)

1. Pham T, Claudepierre P, Constantin A, de Bandt M, Fautrel B, Gossec L, et al. Tocilizumab: therapy and safety management. Joint Bone Spine 2010;77 Suppl 1:S3-100.
2. Laurent S, Le Parc JM, Clerici T, Bréban M, Mahé E. Onset of psoriasis following treatment with tocilizumab. Br J Dermatol 2010;136:1364-5.
3. Ogata A, Umegaki N, Katayama I, Kumanogoh A, Tanaka T. Psoriatic arthritis in two patients with inadequate response to treatment with tocilizumab. Joint Bone Spine 2011 Sep 29 [E-pub ahead of print.]
4. Brulhart L, Nissen MJ, Chevallier P, Gabay C. Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists. Joint Bone Spine 2010;77:625-6.
5. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989;86:6367-71. (Pubitemid 19210653)
6. Zalewska A, Glowacka E, Wyczolkowska J, Tchorzewski H, Narbutt J, Sysa-Jedrzejowska A. Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis. Mediators Inflamm 2006;2006:81767.
7. Wendling D, Balblanc JC, Briançon D, Brousse A, Lohse A, Deprez P, et al. Onset or exacerbation of cutaneous psoriasis during TNF-alpha antagonist therapy. Joint Bone Spine 2008;75:315-8.
8. Markatseli TE, Kaltsonoudis ES, Voulgari PV, Zioga A, Drosos AA. Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol 2009;27:996-8.
9. Florent A, Albert C, Giacchero D, Roux C, Euller-Ziegler L. Reactivation of cutaneous psoriasis during abatacept therapy for spondyloarthropathy. Joint Bone Spine 2010;77:626-7.